Searle & Co’s CareDx CDNA Stock Holding History

Searle & Co’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,700	Closed	-$248K	–	150
2022 Q1	$248K	Buy	+6,700	New	+$261K	0.09%	139
2021 Q4	–	Sell	-3,600	Closed	-$228K	–	161
2021 Q3	$228K	Hold	3,600	–	–	0.09%	137
2021 Q2	$329K	Buy	+3,600	New	+$286K	0.13%	114

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Searle & Co's CDNA Position: Q2 2022 in Review

Searle & Co sold out of CareDx (CDNA) in Q2 2022, closing a stake of 6,700 shares — an estimated $248K sold.

Searle & Co first reported a position in CDNA in Q2 2021 and held it in 3 quarters. The position peaked at $329K in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

Searle & Co reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
Searle & Co sold 6,700 CareDx shares in Q2 2022, an estimated $248K.
Searle & Co first reported a position in CareDx in Q2 2021 and held it in 3 quarters.
Searle & Co's CareDx position peaked at $329K in Q2 2021.
184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Searle & Co's 13F filing for Q2 2022, filed 3 Aug 2022.